Last reviewed · How we verify
Standard medical therapy (SMT) — Competitive Intelligence Brief
phase 3
General Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard medical therapy (SMT) (Standard medical therapy (SMT)) — Post Graduate Institute of Medical Education and Research, Chandigarh. Standard medical therapy involves the use of established treatments to manage a medical condition.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard medical therapy (SMT) TARGET | Standard medical therapy (SMT) | Post Graduate Institute of Medical Education and Research, Chandigarh | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard medical therapy (SMT) CI watch — RSS
- Standard medical therapy (SMT) CI watch — Atom
- Standard medical therapy (SMT) CI watch — JSON
- Standard medical therapy (SMT) alone — RSS
Cite this brief
Drug Landscape (2026). Standard medical therapy (SMT) — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-medical-therapy-smt. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab